期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

晚期非小细胞肺癌的维持治疗 被引量：1

Maintenance treatment of advanced non-small cell lung cancer
原文传递
导出
摘要 目前晚期非小细胞肺癌（NSCLC）一线治疗标准是以铂类为基础的双药化疗.标准疗程化疗后当疾病处于控制状态时下一步处理存在着很大争议,维持治疗逐渐应用于晚期NSCLC的治疗中.晚期NSCLC维持治疗可分为继续维持治疗与换药维持治疗,目前多用于维持治疗的培美曲塞和厄洛替尼已被证实可提高总体生存率. Currently platinum-based double chemotherapy is the standard first-line treatment for advanced non-small cell lung cancer （ NSCLC ）. When the disease is under control, the next step after a stand- ard course of chemotherapy is controversial, and maintenance treatment is used in the treatment of advanced NSCLC increasingly. Maintenance treatment of advanced NSCLC includes continue maintenance treatment and medication changed maintenance therapy, currently used for maintenance therapy with pemetrexed and erlotinib are shown to improve overall survival, which are usually used for maintenance treatment.
作者 吕昆象 李文辉 侯宇 张明 王丽 奚江
机构地区 云南省肿瘤医院昆明医科大学第三附属医院放疗科
出处 《国际肿瘤学杂志》 CAS 2014年第4期283-285,共3页 Journal of International Oncology
关键词 癌 非小细胞肺 维持治疗 靶向治疗 Carcinoma, non-small-cell lung Maintenance treatment Targeted therapy
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献23

  • 1Thill PG, Goswami P, Berchem G, et al. Lung cancer statistics in Luxembourg from 1981 to 2008[J]. Bull Soc Sci Med Grand Duche Luxemb, 2011 (2): 43-55.
  • 2Carney DN. Lung cancer-time to move on from chemotherapy[J].N Engl J Med, 2002, 346(2) : 126-128.
  • 3Vidal L, Scalles G, Gafter-Gvili A, et al. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated system- atic review and meta-analysis of randomized trials [ J ]. J Natl Cancer lnst, 2011, 103(23) : 1799-1806.
  • 4Salles G, Seymour JF, Offner F, et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma respon- ding to rituximab plus chemotherapy (PRIMA) : a phase 3, random- ised controlled trial[J]. Lancet, 2011, 377(9759) : 42-51.
  • 5McCarthy PL, Owzar K, Hurd DD, et al. Lenalidomide after stem- cell transplantation for multiple myeloma[ J]. N Engl J Med, 2012, 366(19) : 1770-1781.
  • 6Gerber DE, Schiller JH. Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea [ J 1. J Clin Oncol, 2013, 31(8) : 1009-1020.
  • 7Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance peme- trexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study[J]. Lancet, 2009, 374(9699) : 1432-1440.
  • 8Fidias PM, Dakhil SR, Lyss AP, et al. Phase 111 study of immediate compared with delayed docetaxel after front-line therapy with gemcit- abine plus carboplatin in advanced non-small-cell lung cancer[J]. J Clin Oncol, 2009, 27(4) : 591-598.
  • 9Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate [ J ]. Cancer Treat Rep, 1979, 63(11-12): 1727-1733.
  • 10Bertolini F, Pual S, Mancuso P, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor ceils [J]. Cancer Res, 2003, 63(15) : 4342-4346.

二级参考文献11

  • 1罗扬,冯奉仪,要洁,张湘茹,王绿化,张德超.231例非小细胞肺癌术后生存和预后分析[J].中国肿瘤临床,2005,32(2):92-94. 被引量：11
  • 2Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 1995, 311 (7010) :899-909.
  • 3Okada M, Nishio W, Sakamoto T, et al. Evolution of surgical outcomes for non-small-cell lung cancer:timetrends in 1465 consecutive patients under going completer setion. Ann Thorac Surg, 2004, 77 (6) :1926-1930.
  • 4Furuse K, Fukuoka M, Kawahara M, et al. A randomized phase Ⅲ study of an current versus sequential thoracic radiotherapy in combination with mitomycin, videsine and cisplatin in unresected stage Ⅲ non-small-cell lung cancer. J Clin Oncol. 1999, 17(9):2609-2699.
  • 5Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG)4588: preliminary results of a phase trim in regionally advanced, unresectable non- small- cell lung cancer. J Natl Cancer Inst, 1995, 87 (3) : 198-205.
  • 6Pitz CC, Brutel de la Riviere A, Elbers HR, et al. Surgical treatment of 125 patients with non-small cell lung cancer and chest wall involvement. Thorax , 1996, 51(8) :846-850.
  • 7Jett JR, Scott WJ, Rivera MP, et al. Guidelines on treatment of stage ⅢB non-small cell lung cancer. Chest, 2003, 123( 1 Suppl) :221S-225S.
  • 8Sirzen F, Kjellen E, Sorenson S, et al. A systematic overview of radiationtherapy effect in non-small cell lung cancer. Acta Oncol, 2003, 42(5/6) :493-515.
  • 9刘叙仪,王洁,方健,吴梅娜,安彤同.355例晚期非小细胞肺癌预后因素分析[J].中国肺癌杂志,2002,5(6):416-419. 被引量：27
  • 10刘顺寿,魏峰,罗全.1667例肺癌外科治疗的多因素预后分析[J].实用肿瘤学杂志,2003,17(1):34-36. 被引量：8

共引文献2

同被引文献18

引证文献1

二级引证文献2

国际肿瘤学杂志
2014年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部